Luye Pharma’s Innovative Formulation LY03010 Meets Endpoints in Pivotal U.S. Study

China’s First Denosumab Biosimilar Boyoubei® Approved for Launch by NMPA

Luye Pharma’s Class 1 Innovative Antidepressant Ruoxinlin® Approved for Launch in China

Boan Biotech’s BA2101 Injection Approved for Clinical Trials in China

It’s China’s First Long-acting Anti-IL-4Rα Monoclonal Antibody

MoU for Strategic Collaboration on Innovative Vaccine Center Signed between Luye Life Sci...

To jointly build the Uzbekistan Innovative Vaccine Center

Boan Biotech’s Broad-Spectrum Neutralizing Antibody BA-CovMab Injection Approved for Clin...